Cardiodepressant effect of itraconazole


Current Problems in Pharmacovigilance, Committee on Safety of Medicines. (Medicine Controls Agency) Vol 27 , August 2001


Itraconazole is a broad spectrum triazole antifungal agent, for the treatment of fungal skin infections, onchomycosis, candidiasis and systemic fungal infections. Oral formulations have been licensed since 1989 and an intravenous (IV) formulation has been marketed in the UK since early 2001. Approximately 67 million patients have received itraconazole worldwide.